| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fe27650e344af1452efd8380bde0fc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0afe637c6f010605a82c9b7134d66434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26d2f8df3e52602dfa6c908fdcf27ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63c49871bf123796eb64f282c8264ce4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-18 |
| filingDate |
2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19904004b9b0588a457fe220c112718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b8ea3423d8f5b9219b5cdaffc5e9c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfe6b9670a6112ffa998f0c921d92c5 |
| publicationDate |
2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8202995-B2 |
| titleOfInvention |
Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same |
| abstract |
The present invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. Also, the present invention discloses methods for preparing the pharmaceutically acceptable salts. These pharmaceutically acceptable salts are suitable for use in treating and/or preventing hyperglycemic disease and/or several oxidative stress related diseases. |
| priorityDate |
2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |